Us Bancorp \De\ Elanco Animal Health Inc Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 12,560 shares of ELAN stock, worth $106,006. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,560
Previous 15,032
16.44%
Holding current value
$106,006
Previous $220,000
30.91%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ELAN
# of Institutions
443Shares Held
444MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$702 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$432 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$412 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$197 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$172 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $4B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...